Keratoconus in a child with partial trisomy 13

Ophthalmic Genet. 2021 Jun;42(3):360-363. doi: 10.1080/13816810.2021.1897849. Epub 2021 Apr 16.

Abstract

Background: Clinical studies suggest the importance of genetic components in the etiology of keratoconus. However, the contributing genes and variants remain elusive. We present a case of bilateral keratoconus in a child with partial trisomy 13, with a trisomic region spanning loci that have been associated with keratoconus.Materials and Methods: This is a single, retrospective case report of a child with a molecular diagnosis of partial trisomy 13, who was diagnosed with bilateral keratoconus for which at the age of 11 years, she underwent successive epithelium-off corneal cross-linking (CXL) procedures in both eyes, followed by temporary central tarsorrhaphy under general anesthesia.Results: Patient's molecular diagnosis was 70 Megabase trisomic region 13q14.11q34. Pre CXL pachymetry was 426 μm and 496 μm, maximum K values were 52.28 D and 55.45 D in right and left eyes, respectively; at last follow up (12 months post-op) these were 494 μm and 509 μm for pachymetry and maximum K values 50.50 D and 52.43 D in the right and left eyes, respectively. No signs of progression were detected.Conclusion: To the best of our knowledge, this is the first case report to document bilateral keratoconus in a child with partial trisomy 13, in whom successful epithelium-off CXL was achieved with general anesthesia. We emphasize the importance of screening, early diagnosis, and therapy of this treatable but rare cause of decreased vision in partial trisomy 13 patients.

Keywords: Keratoconus; corneal collagen cross-linking; partial trisomy 13.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Collagen / metabolism
  • Corneal Pachymetry
  • Corneal Stroma / drug effects
  • Corneal Stroma / metabolism
  • Corneal Topography
  • Cross-Linking Reagents / therapeutic use
  • Female
  • Follow-Up Studies
  • Humans
  • Keratoconus / diagnostic imaging
  • Keratoconus / drug therapy
  • Keratoconus / genetics*
  • Photochemotherapy / methods
  • Photosensitizing Agents / therapeutic use
  • Retrospective Studies
  • Riboflavin / therapeutic use
  • Tomography, Optical Coherence
  • Trisomy / genetics*
  • Trisomy 13 Syndrome / genetics*
  • Visual Acuity

Substances

  • Cross-Linking Reagents
  • Photosensitizing Agents
  • Collagen
  • Riboflavin